Plain-English translation of NCT07397624 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
This trial is testing endoscopic suture gastroplasty (ESG), a minimally invasive procedure that uses stitches to reduce the size of your stomach and help you lose weight. The study focuses on women who have been treated for endometrial cancer and have obesity, because extra weight increases the risk that cancer could return. Researchers want to see if this procedure is safe and helps women achieve lasting weight loss.
Obesity is a major risk factor for endometrial cancer and makes it more likely the cancer will come back. While traditional weight loss surgery works well, it has risks and cannot be reversed. This trial exists to see if the new treatment—a less invasive option—could offer women a safer, reversible way to lose weight and reduce their cancer risk.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will receive the endoscopic suture gastroplasty procedure, which uses tiny stitches placed inside your stomach through an endoscope (a thin camera tube). You will also participate in a structured lifestyle and diet modification program with regular medical supervision. You will need to attend follow-up visits, complete blood tests, meet with dietitians, and commit to lifelong dietary changes as required by the treatment.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Italy